Research interests include the diagnosis and treatment oral mucosal diseases with a focus on pre-cancerous/cancerous conditions of the oral cavity
Oral & Maxillofacial Patholology – Biopsy Service and Clinical Care
Rockafellow A, Florin W, Philipone E
, Koslovsky D. Pregnancy Tumor in a 31-Year-Old Female with a Facial Port-Wine Stain. Case Rep Dent. 2015; Epub 2015 Dec 20.Philipone E
, Bhagat G, Alobeid B.Oral Cavity Lymphoid Neoplasms. A Fifteen-Year Single Institution Review. N Y State Dent J. 2015 Apr;81(3):44-7.Philipone E
, Rockafellow A, Sternberg R, Yoon A, Koslovsky D. Oral ulcerations as a sequela of tacrolimus and mycophenolate mofetil therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Dec;118(6): 175-8.
Yoon AJ, Wang S, Shen J, Robine N, Philipone E
, Oster MW, Nam A, Santella RM. Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma. Am J Transl Res. 2014 Oct 11;6(5):580-92.
Rockafellow A, Ko E, Philipone E
. Asymptomatic gingival lesion occurring in an 83-year-old man. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jul;118(1):5-8.
Ko E, Brouns ER, Korones DN, Pochal WF, Philipone EM
, Zegarelli DJ, Yoon AJ. Primary Ewing sarcoma of the anterior mandible localized to the midline. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):e46-50.
Yoon AJ, Cheng B, Philipone E
, Turner R, Lamster IB. Inflammatory biomarkers in saliva: assessing the strength of association of diabetes mellitus and periodontal status with the oral inflammatory burden. J Clin Periodontol. 2012 May;39(5):434-40.
Yoon AJ, Shen J, Santella RM, Philipone EM
, Wu HC, Eisig SB, Blitzer A, Close LG, Zegarelli DJ. Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic Lesions. J Orofac Sci. 2012;4(10):43-50.
Predictive Value of MicroRNAs in the Progression of Oral Leukoplakias
To assess the differential miR expression profiles in non dysplastic and low grade oral leukoplakia archived tissue and correlate it with known clinical outcome [progression vs non-progression to oral squamous cell carcinoma (OSCC)] with the goal of developing a predictive clinical modality capable of identifying the nondysplastic and low grade oral lesions that are at increased risk of cancer development.
Committees , Council, and Professional Society Memberships
Diplomate – American Board of Oral & Maxillofacial Pathology
Fellow – American Academy of Oral & Maxillofacial Pathology
Member – American Dental Association